Categories: News

Wearable Health Solutions Embarks on Strategic Exploration to Maximize Shareholder Value

NEW YORK, NY / ACCESSWIRE / January 25, 2024 / Wearable Health Solutions Inc. (OTC PINK:WHSI), a provider of age-tech solutions, has initiated a comprehensive review process to assess various strategic options aimed at enhancing shareholder value. In this endeavor, the company has engaged EF Hutton LLC, a leading middle-market investment bank, as our exclusive financial advisor.

The strategic alternatives under consideration may encompass a wide spectrum, including but not limited to potential acquisitions, mergers, business combinations, asset sales or licensing, and other strategic transactions. It is essential to note that the outcome of this ongoing process remains uncertain, both in terms of its success and the specific nature and timing of any prospective developments

As the company proceeds with this strategic review, it is important to emphasize that further disclosures pertaining to this initiative will be limited. The company commits to providing additional information only when a definitive agreement for a transaction is achieved or approved by the Board of Directors, or if it is otherwise determined that additional disclosures are warranted.

For Investor Relations, please visit our website: https://wearablehealthsolutions.com/investor-relations/

Contact Information:
Email: info@wearablehealthsolutions.com

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Securities Exchange Act of 1934, as amended. Any statements that are not historical facts may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Many of these risks and uncertainties are beyond the control of Wearable Health Solutions and are difficult to predict. Additional factors that could cause actual results to differ materially can be found in the most recent quarterly report filed by Wearable Health Solutions with the Securities and Exchange Commission. Wearable Health Solutions assumes no obligation to update any forward-looking statements, except as required by law.

SOURCE: Wearable Health Solutions, Inc.

View the original press release on accesswire.com

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

3 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

3 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

3 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

3 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

3 hours ago